| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/29/1992 | EP0467965A1 Plasmodium circumsporozoite protein analogs lacking repeat sequences |
| 01/29/1992 | EP0467938A1 Assays using albumin-tetrazolium interaction |
| 01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
| 01/29/1992 | CN1058149A Stabilized fibroblast growth factor composition |
| 01/28/1992 | WO1992002634A1 ASSAY, METHODS AND PRODUCTS BASED ON n K+ CHANNEL EXPRESSION |
| 01/28/1992 | WO1992002542A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity |
| 01/28/1992 | WO1992002240A2 Novel methods and compositions for treatment of angiogenic diseases |
| 01/28/1992 | US5084561 Using a zwitterion detergent and extraction |
| 01/28/1992 | US5084559 Protein a domain mutants |
| 01/28/1992 | US5084558 Hemoglobin solution formed by fraction of blood, separation and crosslinking |
| 01/28/1992 | US5084556 A polypeptide conjugated to a cytotoxic agent as an anticancer agent |
| 01/28/1992 | US5084555 Anticarcinogenic agents, gastrointestinal disorders and diabetic agents |
| 01/28/1992 | US5084444 Anticoagulants and enzyme inhibitors |
| 01/28/1992 | US5084442 Cyclic polypeptides as growth hormones |
| 01/28/1992 | US5084441 Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance |
| 01/28/1992 | US5084398 A support with polypeptide binders of proteins |
| 01/28/1992 | US5084391 Monoclonal antibody to the interleukin-2-receptor and its use |
| 01/28/1992 | US5084384 Secretion of insulin-like growth factor-I |
| 01/28/1992 | US5084383 Producing a protein by linking, 5' to 3', and a promoter, a sequencer coding for a peptide, genetic engineering, cultures |
| 01/28/1992 | US5084275 Processes of preparing α-amylase inhibiting subtances from wheat |
| 01/28/1992 | CA2088162A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity |
| 01/28/1992 | CA2087268A1 Assay, methods and products based on nk+ channel expression |
| 01/28/1992 | CA2082804A1 Methods and compositions for treatment of angiogenic diseases |
| 01/28/1992 | CA1295087C Purification of recombinant beta-interferon incorporating rp-hplc |
| 01/28/1992 | CA1295086C 4-aminobutanoic acid derivatives, process of preparation and usethereof |
| 01/28/1992 | CA1294904C Progesterone assay method for mammals |
| 01/28/1992 | CA1294902C Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
| 01/28/1992 | CA1294901C Monoclonal antibody specific for human colon fibroblast-derived t-pa |
| 01/28/1992 | CA1294900C Gentamicin-resistance genes and their use as markers |
| 01/28/1992 | CA1294879C Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone dna, and a method for administering bgh in vivo |
| 01/28/1992 | CA1294873C Method of regulating animal reproduction |
| 01/27/1992 | WO1992001935A1 Cell necrosis detection through assays for spectrin and breakdown products thereof |
| 01/27/1992 | CA2088050A1 Cell necrosis detection through assays for spectrum and breakdown products thereof |
| 01/26/1992 | WO1992001787A1 Binding domains |
| 01/26/1992 | WO1992001465A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 01/26/1992 | CA2087979A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 01/26/1992 | CA2087095A1 Binding domains |
| 01/26/1992 | CA2047769A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/25/1992 | WO1992001790A1 Endogenously sweetened transgenic plant products |
| 01/25/1992 | WO1992001712A1 Analogs of hirudin |
| 01/25/1992 | WO1992001711A1 Polypeptide compounds having growth hormone releasing activity |
| 01/25/1992 | WO1992001709A1 Process for synthesizing peptides |
| 01/25/1992 | CA2086928A1 Polypeptide compounds having growth hormone releasing activity |
| 01/25/1992 | CA2086416A1 Process for synthesizing peptides |
| 01/25/1992 | CA2066749A1 Analogs of hirudin |
| 01/25/1992 | CA2047585A1 Herpesvirus-based viral vector which expresses a foot and mouth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles, and vaccine against foot and mouth disease containing the same |
| 01/25/1992 | CA2047527A1 Method for administering a therapeutic anticoagulant |
| 01/24/1992 | CA2047618A1 Use of particular compounds for manufacture of pharmaceutical formulations for metabolic treatments |
| 01/24/1992 | CA2047540A1 Continuous release pharmaceutical compositions |
| 01/23/1992 | WO1992001058A1 Hybridomas |
| 01/23/1992 | WO1992001057A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | WO1992001056A1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 01/23/1992 | WO1992001054A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 01/23/1992 | WO1992001052A1 Dna coding for human fk506-binding protein and expression thereof |
| 01/23/1992 | WO1992001050A1 Novel receptor-type phosphotyrosine phosphatase |
| 01/23/1992 | WO1992001049A2 Cd53 cell surface antigen and use thereof |
| 01/23/1992 | WO1992001048A1 Production of aprotinin in methylotrophic yeast cells |
| 01/23/1992 | WO1992001044A1 Mouse/human heterohybrid cell line el41 and methods for the production of human monoclonal antibodies |
| 01/23/1992 | WO1992001000A1 Basophil granule proteins |
| 01/23/1992 | WO1992000999A1 Fibroblast growth factor receptors |
| 01/23/1992 | WO1992000997A1 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 01/23/1992 | WO1992000994A1 Growth-promoting agent |
| 01/23/1992 | WO1992000993A1 Isolation and purification of lung surfactant protein |
| 01/23/1992 | WO1992000987A1 Primate lentivirus vaccines |
| 01/23/1992 | WO1992000986A1 Nucleic acid sequences encoding a human dopamine d1 receptor |
| 01/23/1992 | WO1992000956A1 Inhibitors of aspartic proteases |
| 01/23/1992 | WO1992000954A1 Aspartic protease inhibitors |
| 01/23/1992 | WO1992000948A1 Inhibitors of retroviral proteases |
| 01/23/1992 | WO1992000757A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | WO1992000751A1 A pharmaceutical composition comprising a cell adhesion molecule |
| 01/23/1992 | WO1992000745A1 Collagen-based viscoelastic solution for visco-surgery |
| 01/23/1992 | DE4124058A1 Glyco haemoglobin measurement by HPLC - by simultaneously sepg. glyco haemoglobin, haemoglobin and haemoglobin derivs. and removing labile haemoglobin to measure stable haemoglobin |
| 01/23/1992 | CA2087019A1 Nucleic acid sequences encoding a human dopamine d1 receptor |
| 01/23/1992 | CA2087008A1 Novel receptor-type phosphotyrosine phosphatase |
| 01/23/1992 | CA2086932A1 Basophil granule proteins |
| 01/23/1992 | CA2086829A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | CA2086739A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | CA2086014A1 Collagen-based viscoelastic solution for visco-surgery |
| 01/22/1992 | EP0467839A1 In vitro processing of fusion proteins |
| 01/22/1992 | EP0467714A1 The class II protein of the outer membrane of neisseria meningitidis |
| 01/22/1992 | EP0467701A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467700A2 Coconjugate vaccines comprising immunogenic protein, HIV related peptides, and anionic moieties |
| 01/22/1992 | EP0467699A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467676A2 Temperature-inducible secretion expression vectors and their use in prokaryotic cells |
| 01/22/1992 | EP0467536A2 Method of treating bladder cancer cells |
| 01/22/1992 | EP0467433A1 Use of a centrally acting ATCH analog in the manufacture of a medicament |
| 01/22/1992 | EP0467366A2 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents |
| 01/22/1992 | EP0467279A2 Polypeptides having c-AMP producing activity |
| 01/22/1992 | EP0466966A1 Synthetic chondroitin sulfate proteoglycan and process for producing the same |
| 01/22/1992 | EP0466912A1 Glutathione-s-transferase sm26 of s. mansoni |
| 01/22/1992 | EP0466901A1 Dna segments and transformed microorganisms comprising the gene of delta-1 -dehydrogenase, and uses thereof. |
| 01/22/1992 | EP0466854A1 T cell growth factor |
| 01/22/1992 | EP0466817A1 Recombinant trichosanthin and coding sequence |
| 01/22/1992 | EP0466816A1 Method for enhancing transmembrane transport of exogenous molecules |
| 01/22/1992 | EP0466815A1 Infectious targetted replication-defective virion |
| 01/22/1992 | EP0466811A1 Brassica linkage map |
| 01/22/1992 | EP0466806A1 Phosphatidylinositol linking of proteins |
| 01/22/1992 | EP0466780A1 Megakaryocyte growth promoting activity |
| 01/22/1992 | EP0432218A4 Method for detecting cellular pathology |
| 01/22/1992 | CN1058022A Method for preparing interferon alpha-2 crystals |